Indications |
Intravenous Induction and maintenance of general anaesthesia Adult: Induction: 40 mg by inj or infusion every 10 sec. Usual dose: 1.5-2.5 mg/kg. Maintenance: 4-12 mg/kg/hr or intermittent bolus inj of 20-50 mg. Child: >8 yr: Induction dose of 2.5 mg/kg. Maintenance dose: 9-15 mg/kg/hr by IV infusion or intermittent bolus inj. Elderly: Including neurosurgical and debilitated patients: Infuse at a rate of 20 mg every 10 sec. Maintenance: 3-6 mg/kg/hr. Usual dose needed: 1-1.5 mg/kg. Intravenous Sedation Adult: In diagnostic and surgical procedures: Initially, 6-9 mg/kg/hr by infusion given for 3-5 minutes or an alternative dose of 0.5-1 mg/kg by slow inj over 1-5 minutes. Maintenance: 1.5-4.5 mg/kg/hr infusion. Reduce maintenance dose by 20% for high-risk patients needing sedation. For ventilated patients: 0.3-4 mg/kg/hr by infusion. Monitor lipid concentrations if duration of sedation lasts >3 days. Special Populations: Reduce dose by 20% for high-risk patients needing sedation. |
Contraindications |
Electroconvulsive therapy, obstetrics. Sedation in children ≤16 yr. Pregnancy, lactation. |
Warnings / Precautions |
Paediatrics, elderly, hypovolaemia, epilepsy, lipid disorders, patients with increased intracranial pressure. Avoid rapid bolus doses in high risk patients. Emulsion formulation of propofol 2% should only be used in children >3 yr. |
Adverse Reactions |
Involuntary muscle movements; nausea, vomiting, headache, fever; pain, burning or stinging at inj site. Potentially Fatal: Apnoea, bradycardia, hypotension, convulsions; anaphylaxis. |
Drug Interactions |
Reduce dose if given with nitrous oxide or halogenated anaesthetics. Increased sedative, anaesthetic and cardiorespiratory effects when used with other CNS depressants. See Below for More propofol Drug Interactions |
Mechanism of Actions |
Propofol is a short-acting anaesthetic given for induction and maintenance of general anaesthesia. Onset: 30 sec. Duration: 3-10 min. Distribution: Extensively redistributed from brain to other tissues; crosses the placenta and enters breast milk. Protein-binding: 95% Metabolism: Extensively hepatic; converted to water-soluble sulfate and glucuronide conjugates. Excretion: Urine (as metabolites); faeces. Elimination half-life:40 min (initial); 4-7 hr (terminal). |
ATC Classification |
N01AX10 - propofol ; Belongs to the class of other general anesthetics. |
Available As |
|
Propofol
Post Review about Propofol Click here to cancel reply.
Propofol Containing Brands
Propofol is used in following diseases
Drug - Drug Interactions of Propofol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.